KRP 297 (Synonyms: MK-767) |
Catalog No.GC48521 |
KRP 297 es un agonista de PPARα y PPARγ potencialmente para el tratamiento de la diabetes tipo 2 y la dislipidemia.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 213252-19-8
Sample solution is provided at 25 µL, 10mM.
KRP 927 is a thiazolidinedione dual agonist of PPARα and PPARγ (EC50s = 149 and 83 nM, respectively, in transactivation assays).1 It decreases hyperglycemia and hyperinsulinemia in ob/ob mice in a dose-dependent manner. KRP 927 (10 or 30 mg/kg) reduces serum total cholesterol and triglyceride levels in hamsters.
1.Doebber, T.W., Kelly, L.J., Zhou, G., et al.MK-0767, a novel dual PPARα/γ agonist, displays robust antihyperglycemic and hypolipidemic activitiesBiochem. Biophys. Res. Commun.318(2)323-328(2004)
Average Rating: 5
(Based on Reviews and 35 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *